52-Week Performance Chart

Powered by FactSet Research Systems Inc

Corporate Actions/Books Closed

More
Jan 31, 2025
BioLineRX - Books Closed / Open Announcement
Jan 17, 2025
BioLineRx Ltd. - Ratio Change and Reverse Stock Split

Capital Raising Events

More
DR Price Date DR Price (USD) US/Non-US/Total DRS US/Non-US/Total DR Capital Raised
Jan 06, 2025 .20 34,332,122
0
34,332,122
6,866,424
0
6,866,424
Mar 28, 2024 .80 7,500,000
0
7,500,000
6,000,000
0
6,000,000
Sep 18, 2022 1.10 13,636,365
0
13,636,365
15,000,002
0
15,000,002
Jan 19, 2021 2.40 14,375,000
0
14,375,000
34,500,000
0
34,500,000

No DR Events are available.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
Wells Fargo Advisors Financial Network LLC 3,000
BNP Paribas Financial Markets 1,748
RhumbLine Advisers LP 1,530
TOP MUTUAL FUND HOLDERS POSITION

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol BLRX
CUSIP 09071M304
DR Venue NASDAQ Stock Market
DR ISIN US09071M3043
Ratio DR:ORD 1:600
Underlying ISIN IL0011015182
Underlying SEDOL B1RGMP6
Country Israel
Effective Date Jul 25, 2011
Depositary BK (Sponsored)
Industry Pharma. & Biotech.
Books Open/Closed Open
BioLineRx is a late clinical-stage biopharmaceutical development company with a focus on oncology. The Company's development and commercialization pipeline consists of two clinical-stage therapeutic candidates: motixafortide (BL-8040), a peptide for the treatment of stem cell mobilization, solid tumors and acute myeloid leukemia, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the Company has a therapeutic product called BL-5010 for the treatment of skin lesions.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.0500
Cancellation up to $0.0500
Cash Distribution up to $0.0500
Issuance up to $0.0500
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.0500
Rights - Issuance up to $0.0500
Stock Dividend up to $0.0500
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
May.25 5.25 37,015,470 1,762,641
Apr.25 3.47 600,003 28,572
Mar.25 2.96 583,229 27,773

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE